Article
How do we optimally use cetuximab in first-line treatment for metastatic colorectal cancer?
Future oncology (London, England) - 1 Jun 2013
Lindsay Colin R, Roxburgh Patricia, Graham Janet
Abstract excerpt
A number of Phase II/III clinical trials have now been reported assessing the role of cetuximab use in combination with chemotherapy for the first-line treatment of metastatic colorectal cancer. Here we review the current position of cetuximab in this context from two important perspectives. First, we address whether clinicians should prioritize its use with oxaliplatin- or irinotecan-based chemotherapy doublets....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.